CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 2,957,494
- Share change
- -448,563
- Total reported value
- $11,770,877
- Put/Call ratio
- 146%
- Price per share
- $3.98
- Number of holders
- 27
- Value change
- -$1,253,172
- Number of buys
- 8
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
13F
|
Company |
4.9%
|
730,932
|
$3,545,020 | $0 | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
4%
|
598,634
|
$1,867,738 | — | 30 Sep 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
— |
4%
|
598,634
|
$1,618,467 | -$571,171 | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.4%
|
515,465
|
$1,608,251 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
411,786
|
$1,284,773 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
280,869
|
$876,312 | — | 30 Sep 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
1.4%
|
208,143
|
$649,406 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
188,355
|
$587,668 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
168,132
|
$524,572 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
101,621
|
$317,101 | — | 30 Sep 2025 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
72,513
|
$226,240 | — | 30 Sep 2025 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| Joey A. Jacobs |
3/4/5
|
Director |
—
class O/S missing
|
98,415
|
$167,306 | — | 14 Jan 2023 | |
| BlackRock, Inc. |
13F
|
Company |
0.35%
|
52,129
|
$162,643 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.29%
|
44,288
|
$138,000 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
41,445
|
$129,308 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
37,591
|
$117,284 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
33,700
|
$105,144 | — | 30 Sep 2025 | |
| Heron Bay Capital Management |
13F
|
Company |
0.21%
|
31,664
|
$98,792 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
19,603
|
$61,161 | — | 30 Sep 2025 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.12%
|
18,475
|
$57,642 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
10,591
|
$33,044 | — | 30 Sep 2025 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.05%
|
7,742
|
$24,155 | — | 30 Sep 2025 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
3,605
|
$11,247 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
827
|
$2,580 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
787
|
$2,455 | — | 30 Sep 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
756
|
$2,359 | — | 30 Sep 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
600
|
$1,854 | — | 30 Sep 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
345
|
$1,076 | — | 30 Sep 2025 | |
| Capital Advisors, Ltd. LLC |
13F
|
Company |
0%
|
437
|
$1,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
17
|
$53 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
4
|
$12 | — | 30 Sep 2025 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Sep 2025 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q4 2025
As of 31 Dec 2025,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,957,494 shares.
The largest 10 holders included
Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, J. Goldman & Co LP, and Bank of New York Mellon Corp.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
30
Q4 2025 holders
27
Holder diff
-3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.